Yulug, B. Et Al. 2023. Combined metabolic activators improve cognitive functions in Alzheimer's disease patients: a randomised, double-blinded, placebo-controlled phase-II trial. TRANSLATIONAL NEURODEGENERATION , vol.12, no.1 .

Yulug, B., Altay, O., Li, X., Hanoglu, L., Cankaya, S., Lam, S., ... Velioglu, H. A.(2023). Combined metabolic activators improve cognitive functions in Alzheimer's disease patients: a randomised, double-blinded, placebo-controlled phase-II trial. TRANSLATIONAL NEURODEGENERATION , vol.12, no.1.

Yulug, Burak Et Al. "Combined metabolic activators improve cognitive functions in Alzheimer's disease patients: a randomised, double-blinded, placebo-controlled phase-II trial," TRANSLATIONAL NEURODEGENERATION , vol.12, no.1, 2023

Yulug, Burak Et Al. "Combined metabolic activators improve cognitive functions in Alzheimer's disease patients: a randomised, double-blinded, placebo-controlled phase-II trial." TRANSLATIONAL NEURODEGENERATION , vol.12, no.1, 2023

Yulug, B. Et Al. (2023) . "Combined metabolic activators improve cognitive functions in Alzheimer's disease patients: a randomised, double-blinded, placebo-controlled phase-II trial." TRANSLATIONAL NEURODEGENERATION , vol.12, no.1.

@article{article, author={Burak Yulug Et Al. }, title={Combined metabolic activators improve cognitive functions in Alzheimer's disease patients: a randomised, double-blinded, placebo-controlled phase-II trial}, journal={TRANSLATIONAL NEURODEGENERATION}, year=2023}